Table 1.

Patients at high risk of developing severe COVID-19. Candidates to receive SARS-CoV-2 mAbs.

P a t i e n t s’ a g e s
Any age	Aged ≥ 55 years	Aged 12–17 years
Obesity, BMI ≥ 35 g/m2	Cardiovascular diseases	Single cell disease
Chronic kidney disease	Hypertension	Congenital or acquired heart disease
Diabetes mellitus	COPD	Neurological disorders
Immunosuppressive diseases	Other chronic respiratory diseases	Chronic respiratory diseases
Current immunosuppressive therapies

BMI: body mass index; COPD: chronic obstructive pulmonary disease.